X @Bloomberg
Bloomberg·2026-02-04 11:36
Novo’s CEO is asking investors to trust him that a surge in new prescriptions as obesity drugs get cheaper will eventually revive sales growth. The plunge in shares shows they aren’t yet convinced. https://t.co/SkRjZM0FoI ...